Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Thromboembolism, Hypercoagulopathy, and Antiphospholipid Antibodies in Critically Ill Coronavirus Disease 2019 Patients: A Before and After Study of Enhanced Anticoagulation
Crisis Management, Hematology, Pharmacology,
From Critical Care Explorations
In this study, the authors sought to determine the prevalence of thrombotic events, functional coagulation tests, inflammatory biomarkers, and antiphospholipid antibodies before and after enhanced anticoagulation in critically ill coronavirus disease 2019 patients.
van der Linden J, Almskog L, Liliequist A, et al.
Estimated Time: 15:56 min